Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • White paper: Are we prepared for the influx of CAR-Ts?

    March 1, 2022 | Market Access, oncology 

    Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies

    With CAR-Ts continuing to take centre stage as a paradigm shift in the treatment of cancer, Tania Rodrigues investigates how market access and hospital processes will need to transform to accommodate the influx of these innovative therapies.

    Download the white paper here: https://bit.ly/36T8d5j

    This content was provided by Inizio

    Company Details

    - PMLiVE

    Inizio

    Email
    Website

     Latest Content from  Inizio 

    Pegasus scoops five ‘Consultancy’ wins, making 2016 a stellar year for the health comms consultancy

    Pegasus, an Ashfield company, part of UDG Healthcare plc, last night scooped its fifth ‘consultancy’ award of the year at the PRCA Awards in London’s Park Lane where it secured...

    Free Thinking – US Presidential Election: The legacy of the Affordable Care Act and the future for healthcare

    Our latest Free Thinking white paper explores the legacy of the Affordable Care Act and the future for healthcare

    Pegasus crowned PR Week’s Specialist Consultancy of the Year, making a hat-trick of Consultancy wins in 2016!

    Pegasus, an Ashfield company, part of UDG Healthcare plc, is delighted to have been crowned Specialist Consultancy of the Year at this week’s prestigious PR Week Awards. The accolade tops...

    Therapy Watch market snapshots

    Therapy Watch is a ‘real-time’ syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. Run entirely online to ensure speed,...

    Case Study: Private market opportunity for a travel vaccine

    Our client needed exploratory research to determine the global opportunity for a new travel vaccine in the private market. It was crucial to determine:Which markets had the highest potential to...

    Infographic: Conference Live

    Conference Live gives you real-time insights, utilising the multimedia functionality of the smartphone in an innovative mobile app methodology. We conduct mobile conference research amongst physicians attending conferences, giving our clients...

    Blog: The Cost of Counterfeits

    The sale of counterfeit drugs is growing at twice the rate of legitimate pharmaceuticals and pharma companies stand to lose more than just profits from the fallout of counterfeit identification.

    Video: Self-pay and Emerging Markets

    A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public...

    News: Therapy Watch HCV expands into 4 additional EU markets

    The HCV market has been growing and changing remarkably quickly and with the development of new and improving drugs, the treatment of HCV has moved on in a short space...

    News: Research Partnership launches new patient report – Living with Ulcerative Colitis

    Living with UC is a quantitative study conducted online amongst 325 patients, including both adult and paediatric patients diagnosed with ulcerative colitis in 5 EU markets (France, Germany, Italy, Spain...